Sign up to save your podcasts
Or
Share Treatment-Resistant Depression: What is the role of Ketamine, DBS, VNS, TMS, and Psychedelics? Special Guest Dr. Scott Aaronson
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Treatment-Resistant Depression: What is the role of Ketamine, DBS, VNS, TMS, and Psychedelics? Special Guest Dr. Scott Aaronson
Join the Editors of The Journal of Psychedelic Psychiatry as they discuss Treatment-Resistant Depression with Special Guest and Psychiatrist Dr. Scott Aaronson.
Dr. Scott Aaronson obtained his M.D. from Harvard University in 1981. He is currently an Associate Professor at The University of Maryland School of Medicine, a Distinguished Life Fellow of the American Psychiatric Association, a Fellow of The American College of Psychiatrists. He serves on the board of the American Society of Clinical Psychopharmacology and the board of the Clinical TMS Society. He currently is the Director of Clinical Research for The Retreat at Sheppard Pratt.
Referenced Articles on Treatment-Resistant Depression:
https://www.ncbi.nlm.nih.gov/pubmed/30974339
https://journals.sagepub.com/doi/abs/10.1177/0004867418808585?rfr_dat=cr_pub%3Dpubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&journalCode=anpa
Follow us:
Website: https://www.journalofpsychedelicpsychiatry.org/
Twitter: https://twitter.com/psychedelic_org
Facebook: https://www.facebook.com/JournalofPsychedelicPsychiatry/
Instagram: https://www.instagram.com/journalpsychedelicpsychiatry/
View all episodes
By Journal Psychedelic Psychiatry LLC
4.8
2626 ratings
Join the Editors of The Journal of Psychedelic Psychiatry as they discuss Treatment-Resistant Depression with Special Guest and Psychiatrist Dr. Scott Aaronson.
Dr. Scott Aaronson obtained his M.D. from Harvard University in 1981. He is currently an Associate Professor at The University of Maryland School of Medicine, a Distinguished Life Fellow of the American Psychiatric Association, a Fellow of The American College of Psychiatrists. He serves on the board of the American Society of Clinical Psychopharmacology and the board of the Clinical TMS Society. He currently is the Director of Clinical Research for The Retreat at Sheppard Pratt.
Referenced Articles on Treatment-Resistant Depression:
https://www.ncbi.nlm.nih.gov/pubmed/30974339
https://journals.sagepub.com/doi/abs/10.1177/0004867418808585?rfr_dat=cr_pub%3Dpubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&journalCode=anpa
Follow us:
Website: https://www.journalofpsychedelicpsychiatry.org/
Twitter: https://twitter.com/psychedelic_org
Facebook: https://www.facebook.com/JournalofPsychedelicPsychiatry/
Instagram: https://www.instagram.com/journalpsychedelicpsychiatry/